OPN has repeatedly been shown to be present at high levels in the circulation of patients with metastatic cancers [53]–[57] and increased metastatic potential [58]–[60], thus make it relevant in the context of studying its expression in the perspective of metastasis. Here, SPP1 is linked to metastatic malignant neoplasm.